5/24/2018 9 Bibliography

1/6

Bibliography

Dept. of Pharmaceutics, Hindu college of Pharmacy, Guntur Page 79

BIBLIOGRAPHY

1. Parakh SR, Gothoskar AV. A review of mouth dissolving tablet technologies.

Pharm Tech 2003; 27(11):92-98.

2. Chang RK, Guo X, Burnside BA, Cough RA. Fast dissolving tablets. Pharm

Tech 2000; 24(6):52-58.

3. Dobetti L. Fast-melting tablets: Developments and technologies. Pharm Tech

2001;11:44-50.

4. Kuchekar BS, Arumugam V. Fast dissolving tablets. Indian J Pharm Educ

2001;35:150-52.

5. European Directorate for quality of medicines, a new formulation for orally

disintegrating tablets. Pharmeuropa, 1998; 10(4):547.

6. Masaki K: Intrabuccally Disintegrating Preparation and Production Thereof. US

patent 5,466,464, 1995.

7. Reddy LH., Ghose B. Rajneesh. A brief review on fast dissolving drug delivery

systems. Indian J. Pharm. Sci., 2002; 64(4):331-36.

8. Reddy LH, Bijaya G, Bhadhan AC. Mouth dissolve tablets of sumatriptan

succinate. Indian J Pharm Sci 2004; 66(2):238-40.

9. Kuchekar BS, Badhan AC, Mahajan HS. A brief overview on fast dissolving drug

delivery system. Pharma Times, 2003, 35, 7-9.

10. Lalla JK, Sharma AH. An update: Fast dissolving drug delivery system. Indian

Drugs, 1994, 31(11), 503-508.

11. Nail SL, Gatlin LA. In; drying: Principles and Practice, in Pharmaceutical Dosage

Forms-Parenteral Medications, 2nd Edn., Vol.2, Marcel Dekker Inc., New York,

1993,163.

12. Jaccard TT, Leyder JL. Une Nouvelle Forme Galenique. Ann Pharm Fr 1985;

43(2):123-31.

5/24/2018 9 Bibliography

2/6

Bibliography

Dept. of Pharmaceutics, Hindu college of Pharmacy, Guntur Page 80

13. Masaki K. Intrabuccally Disintegrating Preparation and Production Thereof, US

patent No., US5466464, 1995.

14.www.ijpbs.net/download.php?download_file=20.pdf&did=178 .15.http://www.ijaponline.org/Vol3Issue1/142.pdf

16. Swamy PV, Areefulla SH, Shirsand AB, Gandra S, Prashanth B. Orodispersible tablets of

Meloxicam using disintegrant blends for improved efficacy. Ind. J. Pharm.Sci. 2007;

69(6):836-840.

17. Patel DM, Patel NM, Shah RR, Jogani PD, Balapatel AI. Studies in formulation of

orodispersible tablets of rofecoxib. Ind J Pharm Sci 2004; 66(5): 621-25.

18. Harekrishna Roy, Kirti R Parida, Sisir Nandi, Sanjay K Panda, Debendra K

Mohapatra. Design of fast dissolving amlodipine besylate tablet formulations.

Asian J. Pharm.2012; 6: 51-9.19. Sheetal M, Supria S, Kadam VJ .Formulation and

evaluation of oxacarbazine fast dissolving tablets. Ind J Pharm Sci 2007;

69(2):211-14.

19. Sheetal M, Supria S, Kadam VJ .Formulation and evaluation of oxacarbazine fast

dissolving tablets. Ind J Pharm Sci 2007; 69(2):211-14.

20. Jha SK, Vijayalaksmi P, Karki R, Goli D. Formulation and evaluation of melt-in

mouth tablets of haloperidol. Asian J. Pharma 2008 October-December.

21. Shenoy V, Agarwal S, Pandey S. Optimizing fast dissolving dosage form of

diclofenac sodium by rapidly disintegrating agents. Ind. J. Pharm. Sci. 2003: 197-

201.

22. Chowdary KPPR, Rao RN. Formulation and evaluation of Piroxicam tablets with

Piroxicam-Pregelatinized starch dispersions. Indian Drugs 2000; 37(2):99-101.

23. Chowdary KPR, Rao S. Formulation and evaluation of dispersible tablets of poorly

soluble drugs. Ind J Pharm Sci 1991 Jan-Feb; 31-32.

24. Yunxia Bi, Hisakazu S, Yorinobu Y, Kazumi D, Akinobo O. Preparation and

evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem

Pharm Bull 1996; 44(11):2121-27.

http://www.ijaponline.org/Vol3Issue1/142.pdfhttp://www.ijaponline.org/Vol3Issue1/142.pdfhttp://www.ijaponline.org/Vol3Issue1/142.pdfhttp://www.ijaponline.org/Vol3Issue1/142.pdf

5/24/2018 9 Bibliography

3/6

Bibliography

Dept. of Pharmaceutics, Hindu college of Pharmacy, Guntur Page 81

25. Shirsand SB, Sarasija Suresh, Swamy PV, Nagendra KD, Rampura MV. Design

and evaluation of Fast dissolving tablets of lonazepam. Indian J Pharm Sci 2008;

70(6): 791-95.

26. Gattani SG, Shiyani BG, Kakade KN, Patil AB, Surana SJ. Formulation and

evaluation of mouth dissolving tablets of ondansetron hydrochloride. Indian Drugs

2009; 46(1).

27. Mahapatra AK, Murthy PN, Sahoo J, Biswal S, Sahoo SK. Formulation and

optimization of mouth dissolving tablets of levocetirizine hydrochloride using

sublimation technique. Indian J Pharm Educ Res 2009; 43(1).

28. Mulla JA, Dasankoppa FS, Vilas GJ, Sholapur HP. Fast dissolving tablets of

Promethazine: a novel oral formulation for the treatment of fractionated

radiotherapy induced nausea and emesis. Indian drugs 2008; 45(4).

29. Suresh S, Pandit V, Jhoshi HP. preparation and evaluation of mouth dissolving

tablets of salbutamol sulphate. Indian J Pharm Sci 2007; 69(3):467-69.

30. Masareddy RS, Kadia RV, Manvi FV. Development of mouth dissolving tablets of

clozapine using two different techniques. Indian J Pharm Sci 2008; 70(4):526-28.

31. Pandey VP, Venkatrao S, Chakravarthy K. studied on crospovidone for cefadroxil

dispersible tablets. The Indian Pharmacist Feb 2008; 71-74.

32. Ishikawa T, Watanabe Y, Utoguchi N, Matsumoto M. Preparation and evaluation of

tablets rapidly disintegrating in saliva containing bitter taste mask granules by the

compression method. Chem Pharm Bull 1999; 47(10):1451-54.

33. Y.X. Bi, H. Sunada, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating

tablets prepared by direct compression method. Drug development and Industrial

pharmacy 1999; 25(5): 571-581.

34. Scheirmeier S, Peter CS. Fast dispersible ibuprofen tablets. Eur J Pharm Sci 2002;

15: 295-05.

35. Hisakadsu Sunada, Yunxia Bi. Preparation, evaluation and optimization of rapidly

disintegrating tablets. Powder technology 2002; 122:188-98.

5/24/2018 9 Bibliography

4/6

Bibliography

Dept. of Pharmaceutics, Hindu college of Pharmacy, Guntur Page 82

36. Akihiko Ito, Masayasu Sughihara. Development of oral dosage form for elderly

patients: use of agar as a base of rapidly disintegrating oral tablets. Chem Pharm

Bull 1996; 44(11):2132-36.

37. Yoshiteru Watanabe, Koizumi K, Kiriyama M, Matsumato Y. New compressed

tablets rapidly disintegrating in saliva in the mouth using crystalline cellulose as

disintegrant. Biol Pharm Bull 1995; 18(9):1308-10.

38. Biradar SS, Bhagavati ST, Kuppasad IJ. Fast dissolving drug delivery systems. The

Int J Pharmacol 2006; 4(2):1531-36.

39. Ahuja N, Katare OP, Singh B. Studies on dissolution enhancement used

mathematical modelling of drug release of a poorly water-soluble drug using

water-soluble carriers.Eur J Pharm Biopharm 2007; 65:26-38.

40. Saigal, Nitin, Baboota, Ahuja, Ali, Alka, Javed, Sanjula. Fast dissolving intra-oral

drug delivery system. Expert Opinion on Therapeutic Patents 2008; 18(7):769-81.

41. Avinash GT, Larry SW. Rapidly disintegrating and fast dissolving solid dosage

forms. US Patent Publication 2001; 929.

42. Amarjit S, Rajesh J. Fast dissolving composition with prolonged sweet taste. US

Patent Publication 2006.

43. Avani F Amin. Emerging trends in the development of orally disintegrating tablet

technology. Pharmaino.net 2006;.4(1):1-22.

44. Nandgude TD, Chatap VK, Bhise KS, Sharma DK. Mouth dissolving tablets:

geriatrics and paediatrics friendly drug delivery system. Indian Drugs June 2007;

44(6): 471-173.

45. Lim DK, Lee HK, Suh HR, Kim YC, Jung YT, Youn YS, Kang HS. Crystalline

organic acid salt of Amlodipine US Patent Application and Publication 2004.

46. Sridhar K, Sastry CSP, Reddy MN, Sankar DG, Rama S. Spectrophotometric

determination of amlodipine besylate in pure form and tablets. Analytical letters

1997; 30(1):121-33.

5/24/2018 9 Bibliography

5/6

Bibliography

Dept. of Pharmaceutics, Hindu college of Pharmacy, Guntur Page 83

47. Wolfram E. Bilayer tablets of telmisartan and amlodipine. US Patent Publication

2005; 265(11):722.

48. Chung, Calcagni M, Glue A, l Bramson P, Candace. Bioavailability of amlodipine

besylate/atorvastatin calcium combination tablet. J Clinical Pharmacology Sep

2006; 46(9)

49. Available form URL:http://www.en.wikipedia.org/wiki/Amlodipine besylate

50. Ainley Wade, Paul J Weller. Handbook of Pharmaceutical Excipients: Monographs.

London: The Pharmaceutical press; 2000;1:163-164.

51. Ainley Wade, Paul J Weller. Handbook of Pharmaceutical Excipients: Monographs.

London: The Pharmaceutical press; 2000; 2:324-328.

52. Ainley Wade, Paul J Weller. Handbook of Pharmaceutical Excipients: Monographs.

London: The Pharmaceutical press; 2000; 1:27-29.

53. Ainley Wade, Paul J Weller. Handbook of Pharmaceutical Excipients: Monographs.

London: The Pharmaceutical press; 2000;1:3-4.

54. Ainley Wade, Paul J Weller. Handbook of Pharmaceutical Excipients: Monographs.London: The Pharmaceutical press; 2000; 2:505-507.

55. Ainley Wade, Paul J Weller. Handbook of Pharmaceutical Excipients: Monographs.

London: The Pharmaceutical press; 2000; 1:143-146.

56. Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P. Development of sustained

release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo

evaluation. Int J Pharm.2005; 304(1-2):178-84.

57. Aulton ME, Wells TI, Pharmaceutics: The science of dosage form design. London:

Churchill Livingston; 1998. P.247.

58. Martin A, Baltimores MD. Micromeretics physical pharmacy. London: Lippincott

Williams and Wilkins; 2001. P.423-54.

59. Chaudhri PD, Chaudhri SP, Kolhe SR. Formulation and evaluation of fast

dissolving tablets of famotidine. Indian Drugs 2005; 42(10):641-7.

5/24/2018 9 Bibliography

6/6

Bibliography

Dept. of Pharmaceutics, Hindu college of Pharmacy, Guntur Page 84

60. Indian Pharmacoepia. Govt. Of India, ministry of health and family welfare. New

Dehli:The controller of publications; 1996.

61. USP 24: NF 19. Asian Edition. United states Pharmacoepia convention Inc.

62. British Pharmacoepia. London: Her Majestys Stationary Office; 2003.

63.http://www.corelpharmachem.com/kyron.htm

http://www.corelpharmachem.com/kyron.htmhttp://www.corelpharmachem.com/kyron.htmhttp://www.corelpharmachem.com/kyron.htmhttp://www.corelpharmachem.com/kyron.htm